We investigate the role of physician agency in determining health care supply and patient outcomes. We show that an increase in health care supply due to a change in private physician incentives has a theoretically ambiguous impact on patient welfare. The increase can reflect either induced demand for ineffective care or a reduction in prior rationing of effective care. Furthermore, physician market structure matters in determining the welfare effects of changes in private physician incentives. We then analyze a change to Medicare fees that caused physicians to increase their provision of chemotherapy. We find that this increase in treatment improved patient survival, extending median life expectancy for lung cancer patients by about 18%. Consistent with the model, we find that while the treatment response was larger in less concentrated markets, survival improvements were larger in more concentrated markets.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260815 | PMC |
| http://dx.doi.org/10.1016/j.jebo.2016.11.011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Acceptability of risk-based breast cancer screening among professionals and healthcare providers from 6 countries contributing to the MyPeBS study.
BMC Cancer
March 2025
Aix Marseille Univ, Inserm, IRD, ISSPAM, SESSTIM, Marseille, France.
Background: To evaluate the acceptability of a risk-based breast cancer screening (BCS) strategy among professionals involved in MyPeBS study in 6 countries.
Methods: After qualitative interviews, a questionnaire was built with a Delphi method: to evaluate professionals' basic understanding, satisfaction and reactions to each stage of the trial, opinions on BCS and its future. The questionnaire was distributed by emailing 698 investigators, who forwarded it to all categories of professionals involved in trial recruitment (physicians, medical secretaries, nurses, and mammography technicians).
Employment Models to Attract and Sustain Rural Generalist Doctors: Barriers and Enablers.
Aust J Rural Health
April 2025
Department of Health, Victorian Rural Generalist Program, Victoria, Australia.
Objective: Explore the barriers and enablers related to employment models to attract and sustain rural generalist (RG) doctors emerging from a state-wide RG program.
Setting: Stakeholders across five rural regions in Victoria, associated with the Victorian Rural Generalist Program (VRGP).
Participants: 36 stakeholders who responded from a list of 122 potential identified by a state-wide advisory group for the VRGP.
Embracing Medicines Development as a Profession.
Pharmaceut Med
March 2025
The Academy of Global Medicines Development Professionals (GMDP Academy), New York, NY, USA.
Medicines development has dramatically transformed in the preceding decades. It has evolved from a task undertaken by a small team to a complex series of activities, involving several functions and qualified professionals, across multiple, interrelated, scientific disciplines, worldwide. Conceptualized as a medical specialty, concerned with the research, development, and monitoring of medicines, and spearheaded largely by pharmaceutical physicians, the discipline has extended to embrace non-medically qualified scientists progressively taking on traditional roles within the medicines development ambit.
View Article and Find Full Text PDFA toolkit to implement opioid quality improvement efforts in primary care: Findings from a mixed-methods study.
J Opioid Manag
March 2025
Abt Global, LLC, Cambridge, Mas-sachusetts. ORCID: https://orcid.org/0000-0003-3391-2041.
Objective: The Six Building Blocks: A Team-Based Approach to Improving Opioid Management in Primary Care (6BBs) program provides a roadmap for improving the management of patients on opioid therapy for chronic pain. The goal of this project was to evaluate the How-to-Implement Toolkit (Toolkit) for clinics to independently implement the 6BBs without a practice facilitator.
Methods: Eight healthcare organizations with 62 clinics participated in the program.
Access to Transplant for African American and Latino Patients Under the 2014 US Kidney Allocation System.
Transplantation
March 2025
Scientific Registry of Transplant Recipients (SRTR), Minneapolis, MN.
Background: Kidney transplant offers better outcomes and reduced costs compared with chronic dialysis. However, racial and ethnic disparities in access to kidney transplant persist despite efforts to expand access to transplant and improve the equity of deceased donor allocation. Our objective was to evaluate after listing the association of race and ethnicity with access to deceased donor kidney transplant (DDKT) after changes to the allocation system in 2014.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!